logo

NAMI

Jinxin Technology·NASDAQ
--
--(--)
--
--(--)
9.63 / 10
Outperform

Fundamentally, the firm scores 9.6/10, excelling in total profit/EBIT and equity multiplier, while current and non‑current liability ratios are high. The fund‑based composite score is 9.63, indicating superior financial health despite liability concerns.

Fundamental(9.63)SentimentTechnical

Analysis Checks(3/8)

Net cash flow from operating activities per share (YoY growth rate %)
Value-667.97
Score1/3
Weight-3.35%
1M Return-0.11%
Equity multiplier
Value2.04
Score2/3
Weight5.24%
1M Return0.16%
Current liabilities / Total liabilities (%)
Value96.29
Score0/3
Weight-73.12%
1M Return-2.77%
Non-current liabilities / Total liabilities (%)
Value3.71
Score0/3
Weight-91.50%
1M Return-3.55%
Total profit / EBIT (%)
Value99.36
Score2/3
Weight94.42%
1M Return3.20%
Net cash flow from operating activities / Total liabilities (%)
Value0.15
Score2/3
Weight165.40%
1M Return4.51%
Long-term debt to working capital ratio (%)
Value0.06
Score0/3
Weight-34.20%
1M Return-1.20%
Net profit / Total profit (%)
Value100.00
Score1/3
Weight37.09%
1M Return1.45%
Is NAMI undervalued or overvalued?
  • NAMI scores 9.63/10 on fundamentals and holds a Discounted valuation at present. Backed by its -13.48% ROE, -5.86% net margin, -18.65 P/E ratio, 3.39 P/B ratio, and 0.00% earnings growth, these metrics solidify its Outperform investment rating.